Table 4.
Association of VI in 2013 with 10 chronic diseases and multimorbidity new-onset risk and association of VI transition patterns from 2011 to 2013 with 10 chronic diseases and multimorbidity new-onset risk in the CHARLS cohort
| VI in 2013 | VI Change Pattern | |||||||
|---|---|---|---|---|---|---|---|---|
| NoVI-VI vs NoVI-VI | VI-NoVI vs NoVI-NoVI | VI-VI vs NoVI-NoVI | ||||||
| aHR(95%CI) | P | aHR(95%CI) | P | aHR(95%CI) | P | aHR(95%CI) | P | |
| Heart diseases | 1.25(1.01–1.55) | 0.042 | 0.84(0.57–1.24) | 0.388 | 0.90(0.60–1.33) | 0.584 | 1.24(0.91–1.70) | 0.172 |
| Hypertensiona | 1.15(0.98–1.35) | 0.094 | 1.25 (0.94–1.65) | 0.125 | 1.11(0.83–1.50) | 0.484 | 1.22(0.95–1.55) | 0.116 |
| Stroke | 1.14(0.85–1.52 | 0.388 | 0.81(0.46–1.42) | 0.459 | 1.05(0.61–1.80) | 0.873 | 1.24 (0.79–1.95) | 0.342 |
| DM/Hglub | 1.23(0.97–1.56) | 0.086 | 1.08(0.69–1.70) | 0.743 | 1.42(0.91–2.23) | 0.126 | 1.63(1.11–2.38) | 0.012 |
| Liver disease | 1.07 (0.77–1.51) | 0.677 | 1.11 (0.58–2.13) | 0.753 | 1.51(0.79–2.87) | 0.210 | 1.45 (0.84–2.52) | 0.185 |
| Kidney disease | 1.45 (1.05–2.00) | 0.024 | 2.33(1.23–4.39) | 0.009 | 1.86(0.96–3.62) | 0.068 | 2.16(1.20–3.87) | 0.010 |
| Chronic lung disease | 1.32(1.01–1.71) | 0.040 | 1.22 (0.76–1.98) | 0.411 | 1.21(0.74–1.98) | 0.458 | 1.53 (1.02–2.31) | 0.042 |
| Memory-related disease | 1.42(0.95–2.13) | 0.085 | 1.55 (0.69–3.49) | 0.288 | 1.54 (0.68–3.51) | 0.300 | 1.97(0.97–4.03) | 0.062 |
| Asthma | 1.91 (1.12–3.28) | 0.018 | 2.05(0.82–5.08) | 0.123 | 1.04 (0.37–2.94) | 0.936 | 1.94(0.85–4.45) | 0.116 |
| ENP | 1.34 (0.77–2.31) | 0.299 | 0.96 (0.32–2.85) | 0.934 | 1.27(0.43–3.72) | 0.664 | 1.68(0.68–4.16) | 0.263 |
| Multimorbidity | 1.26(1.10–1.45) | 0.001 | 1.33(1.04–1.70) | 0.025 | 1.26(0.97–1.63) | 0.081 | 1.47 (1.19–1.82) | < 0.001 |
All calculated aHRs (95% CI) considered the adjustment for confounding factors including age, sex, BMI, residence registration status, marital status, smoke, drink, level of social and individual activity engagement, physical fitness, grip strength, and medical history of hypertension, dyslipidemia, DM/Hglu
Abbreviations: VI Vision Impairment, DM/Hglu Diabetes or high blood sugar, ENP Emotional, nervous or psychiatric problems
a In the adjusted analysis of confounding factors, a history of hypertension was exclude
b In the adjusted analysis of confounding factors, a history of DM/Hglu was exclude